Slides: Guidelines and the role of non-statin therapies for high risk ASCVD patients
Presentation prof. Wouter Jukema
This lecture by prof. J. Wouter Jukema is part of an educational series of 4 lectures focussed on PCSK9: Outcomes and trials in clinical perspective
View presentation slides
The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.
Share this page with your colleagues and friends: